Selecting the Best Breast Cancer Surgeons and Hospitals in India for Australian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 25-08-2026

Most Australians should never need this guide, and I want to say that plainly before anything else. Australian breast cancer care is close to free at the point of use, delivered through a mature, BreastScreen-supported system, and moving primary curative treatment overseas is rarely the right answer. This guide exists for a narrower group — and it is worth being precise about who that is before a single criterion is discussed.

Healing Journeys of Australian Patients

Australian Patients Share Their Experience

Key Takeaways

• Most Australian breast cancer patients should not need to travel to India for primary treatment. India may be considered for a second opinion, limited reconstruction access, rare or complex presentations, or a faster private surgical pathway.
• Before considering overseas treatment, patients should have the diagnosis fully established in Australia, including biopsy, imaging, ER/PR/HER2 status and relevant genomic testing, and should carry the actual pathology blocks or slides rather than relying only on a typed report.
• The page 2 weighted-criteria chart gives 55% weight to the surgeon and oncology team and 45% to the hospital. Oncoplastic or breast-specific fellowship training receives the highest individual weighting at 15 points, followed by breast-conservation judgement and sentinel lymph-node technique.
• The guide emphasises breast-conservation judgement, sentinel node biopsy and genuine reconstruction options. Patients should ask why conservation or mastectomy is recommended for their tumour and whether immediate implant-based or autologous reconstruction is available.
• The page 3 qualification table identifies MCh/DrNB Surgical Oncology as the base specialist qualification and a 1–2 year fellowship in surgical breast oncology or oncoplastic breast surgery as the most relevant additional training.
• Hospital assessment focuses on a breast-specific tumour board, breast radiology and pathology, ER/PR/HER2 and relevant genomic testing, coordinated medical and radiation oncology, verifiable accreditation and complete records for the Australian oncology team.
• The guide identifies four warning signs: pricing before pathology review, mastectomy without discussion of conservation, vague reconstruction planning and unsupported cure claims. It also recommends informing the Australian breast-care team early and arranging ongoing oncology care before travelling.

Quick Facts

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

Treatment

Breast Cancer Surgery

Patients

Australian Patients

Key Specialist

Breast / Oncoplastic Breast Surgeon

Selection Weighting

55% surgeon & oncology team / 45% hospital

Key Training

Fellowship in Surgical Breast Oncology or Oncoplastic Breast Surgery

Base Qualification

MCh/DrNB Surgical Oncology

Conservation Check

Ask why breast conservation or mastectomy is recommended

Node Check

Sentinel lymph node biopsy where appropriate

Reconstruction

Implant-based or autologous options

Team Check

Breast-specific tumour board

Testing

ER/PR/HER2 and relevant genomic testing

Oncology Support

Medical and radiation oncology coordination

Accreditation

Independently verifiable accreditation

Records

Operative note, final pathology and treatment recommendation

Pre-Travel Check

Actual pathology, imaging and receptor status

Key Warning

Price before pathology review or unsupported cure claims

Decision Principle

Choose breast-specific expertise and a treatment plan your Australian team can confidently continue.

In 24 years of guiding international patients into Indian hospitals, I have turned away more Australians with breast cancer than from almost any other diagnosis, and I would do it again tomorrow. If none of the four reasons above describes your situation, the right next step is a conversation with your Australian breast surgeon, not this document.

In Brief

For Australian patients considering breast cancer surgery in India, the guide recommends verifying the diagnosis first and prioritising breast-specific or oncoplastic expertise, appropriate breast-conservation judgement, sentinel node technique and genuine reconstruction options. Patients should also confirm multidisciplinary tumour-board review and ensure their Australian oncology team can continue care using the complete overseas operative and pathology records.

Before you choose anyone: get the diagnosis pinned down at home

Every criterion below depends on one thing being settled first: an accurate tissue diagnosis, receptor status and, where relevant, genomic testing, obtained in Australia, where Medicare pays for it. A surgeon anywhere in the world can only be as good as the diagnosis he or she is working from, and a disturbing share of the disappointment I see in this specialty traces back to a plan built on an incomplete workup rather than a poorly performed operation.

Get your biopsy, your full imaging — mammogram, ultrasound, and MRI where performed — and your ER/PR/HER2 status confirmed in Australia first. Then carry the actual pathology, blocks or slides rather than a typed report, into every conversation that follows.

This matters more for breast cancer than for many other tumour types, because the decision between breast conservation and mastectomy is genuinely a judgement call in a meaningful share of cases, not a fixed fact read off a scan. A second opinion at a high-volume centre occasionally changes that judgement, and a changed judgement changes the entire operation that follows.

Part one: judging the surgeon and the oncology team

1. Oncoplastic or breast-specific fellowship training. This is the single heaviest criterion in this guide, and deliberately so. A general surgeon who occasionally operates on breast cancer is not the same as a fellowship-trained breast or oncoplastic surgeon, and the difference shows up directly in outcomes that matter to you.

2. Breast-conservation judgement, appropriately used. Ask directly what proportion of the surgeon’s cases are treated with breast conservation versus mastectomy, and how that compares with published benchmarks for similar tumour profiles. Neither a very low nor a suspiciously high conservation rate is automatically reassuring; what matters is a surgeon who can explain the reasoning behind each individual case confidently.

3. Sentinel lymph node technique, not routine full dissection. Sentinel node biopsy, sampling only the first draining lymph nodes rather than removing the full axillary chain, substantially reduces the risk of lymphoedema when it is oncologically appropriate. Ask specifically whether this is standard practice for early-stage disease, and in whose hands.

4. Reconstruction genuinely offered, not an afterthought. Ask whether immediate reconstruction is realistically available at the time of your original surgery, what techniques the surgeon or their reconstructive colleague actually performs — implant-based, or autologous techniques such as a DIEP flap — and ask to see examples of their own work, not stock photography.

5. Volume in breast cancer specifically, and personal involvement. Insist on a video consultation with the surgeon who will actually operate, not a coordinator, before any deposit moves. Ask for their annual volume in breast cancer surgery specifically, not general oncological surgery, and what proportion of their practice this genuinely represents.

Part two: judging the hospital

6. A tumour board that includes breast radiology and breast pathology. Ask whether your case will be reviewed by a genuine multidisciplinary breast tumour board, including a radiologist and pathologist with breast-specific experience, not a general cancer panel. This review is where the conservation-versus-mastectomy decision should genuinely be tested, not decided by one surgeon alone.

7. Genomic and molecular testing on site. Ask whether ER/PR/HER2 testing and, where relevant, a multigene recurrence-risk panel are performed in-house or sent externally, and what the turnaround time is. This result directly determines whether chemotherapy is likely to help you at all.

8. Medical and radiation oncology under one roof. If your treatment plan may include chemotherapy or radiotherapy, confirm both are delivered at the same institution with genuine coordination, rather than a surgical unit that refers elsewhere for everything beyond the operation itself.

9. Accreditation you can verify yourself. JCI is the international arm of the body accrediting hospitals across the United States; NABH is India’s national equivalent, recognised by the same global standards authority. Check either on the accrediting body’s own site rather than accepting the logo on the hospital’s.

10. A record your Australian oncologist can act on. Before you leave you should hold the full operative note, the final pathology report with margins and receptor status clearly stated, and a written recommendation for any further treatment. This is what determines whether your Australian team can pick up your care confidently.

What the quote should say, and what it usually omits

In 24 years I have found that disputes almost never concern the quoted price. They concern what the quote silently omitted.

Insist on a written, itemised figure that states what happens if the plan changes intraoperatively — a wider excision than expected, a positive sentinel node requiring further surgery — and what that would cost. Ask whether reconstruction, if planned, is included in the same figure or billed as a genuinely separate procedure. Ask whether pathology processing, including any send-out molecular testing, is included or billed separately.

Understand what does not travel with you. Medicare pays nothing for treatment received overseas, your health fund rebate applies to Australian admissions, and standard travel insurance excludes planned surgery and its complications. One rule is not negotiable: pay a deposit to secure the date, never the full balance in advance. The remainder is settled on arrival, once the surgeon and the tumour board have confirmed the plan in person.

Four Signals That Should Make You Pause

1. A price quoted before your pathology has been reviewed. Nobody can price breast cancer surgery, particularly if reconstruction is involved, without having seen the tissue and imaging. A number arriving within an hour of your first email is a marketing figure, not a quote.

2. Mastectomy recommended with no discussion of conservation. For many tumour profiles this is a genuine, defensible clinical judgement; for others it is a sign the surgeon defaults to the simpler operation. Ask directly why conservation isn’t being offered in your specific case.

3. Reconstruction discussed vaguely, or only after the cancer surgery is booked. A genuinely oncoplastic-minded team raises reconstruction as part of the original conversation, not as an upsell afterward.

4. Any claim of a cure your Australian oncologist has not heard of. Legitimate breast cancer surgery has no need to oversell itself. Unproven adjuncts marketed alongside a genuine operation are a warning sign about the whole institution.

Australia-specific considerations most patients miss

Tell your Australian breast care team early, not after the fact. Most are more sympathetic to a second opinion or an overseas consultation than patients expect, and a team informed from the outset is far better placed to pick up your care afterwards than one presented with a decision already made.

Arrange your ongoing oncology care before you leave. If chemotherapy or radiotherapy may follow surgery, confirm your Australian medical or radiation oncologist is willing to deliver it based on the overseas surgical findings, and give them the dates in advance.

Send the tissue, not just the report. A pathology re-read or a second surgical opinion requires the actual blocks or slides. A typed summary alone will simply generate a request for the material itself, costing you time you may not have.

Ask about the Medical Treatment Overseas Program. Where a specific technique is genuinely unavailable in Australia, this Commonwealth programme can in some circumstances fund treatment abroad. Ask your specialist whether you might qualify before assuming the whole cost falls on you.

Apply for both visas together. Australian passport holders are eligible for India’s electronic medical visa, issued against an invitation letter from the treating hospital, with an e-medical attendant visa for whoever travels with you.

Ask what happens if the diagnosis changes after surgery. Establish before you travel what the plan becomes if intraoperative or final pathology findings differ from expectation, who tells you, and what it costs. Ask an Australian oncologist the parallel question: would they take over care based on findings from surgery performed overseas? Both answers, taken together, tell you how comfortable this decision should feel.

A closing word

Breast cancer surgery rewards precision more than almost any other decision in this series, because it sits at the intersection of cancer control and a result you will live with for the rest of your life. If your situation is a second opinion, a reconstruction access gap, a rare presentation or a faster private option — verify the diagnosis first, weight oncoplastic training as heavily as the tumour board, and ask about breast-conservation judgement before anything else. If you would like a second opinion on your pathology and imaging, or a review of a quote you are already holding, send them and I will look at it properly — including telling you that your case should stay in Australia, which for breast cancer is an answer I give more often than the alternative.

Sources

• 🌐 Published breast surgical oncology literature on oncoplastic training, breast-conservation rates and re-excision rates
• 🌐 National Medical Commission, recognised postgraduate medical qualifications in surgical oncology and breast oncology
• 🌐 Australian Government Medical Treatment Overseas Program, eligibility criteria
• 🌐 BreastScreen Australia, national screening programme information
• 🌐 Joint Commission International and National Accreditation Board for Hospitals and Healthcare Providers, accreditation registers
• 🌐 High Commission of India, e-Visa categories and eligibility

Frequently Asked Questions by Australians about Breast Cancer Surgeons and Hospitals in India

Should every Australian breast cancer patient travel to India?

No. The guide explicitly states that most Australians should receive their primary breast cancer care in Australia. India may be considered for a second opinion, reconstruction access gap, rare or complex presentation or faster private pathway.

What should I complete before seeking an Indian opinion?

Have your biopsy, imaging, ER/PR/HER2 status and relevant genomic testing completed in Australia where appropriate. Carry the actual pathology blocks or slides when possible.

What qualifications should I check?

Look for MCh/DrNB Surgical Oncology and, particularly, a fellowship in surgical breast oncology or oncoplastic breast surgery.

How should I assess a recommendation for mastectomy?

Ask why breast conservation is not suitable for your specific tumour. The guide stresses that conservation versus mastectomy can involve clinical judgement and should be properly explained.

Why is sentinel lymph-node biopsy important?

When oncologically appropriate, sentinel node biopsy samples the first draining lymph nodes rather than routinely removing the full axillary chain, potentially reducing the risk of lymphoedema.

What should I ask about reconstruction?

Ask whether immediate reconstruction is genuinely available and which techniques the surgeon or reconstructive colleague performs, including implant-based or autologous options such as DIEP flap reconstruction.

Why is a breast-specific tumour board important?

The guide recommends a multidisciplinary review involving breast radiology and breast pathology, because major treatment decisions such as conservation versus mastectomy should not depend on one surgeon’s opinion alone.

What should the quotation include?

Ask for a written, itemised quotation explaining what happens financially if wider excision, further surgery, reconstruction or additional pathology/molecular testing becomes necessary.

Can my Australian oncologist continue my care after surgery in India?

The guide recommends arranging this before travelling and ensuring the Australian team receives the full operative note, final pathology, margins, receptor status and further-treatment recommendations.

What are the main warning signs?

Be cautious if the centre quotes a price before reviewing pathology, recommends mastectomy without discussing conservation, discusses reconstruction only after surgery is booked or makes unsupported claims of a cure.

Page Summary

This guide helps Australian patients evaluate breast cancer surgeons and hospitals in India, with emphasis on oncoplastic or breast-specific fellowship training, breast-conservation judgement, sentinel lymph-node technique, reconstruction, tumour-board review and coordinated oncology care. The page 2 framework gives 55% weight to the surgeon and oncology team and 45% to the hospital, while the guide repeatedly stresses that overseas surgery should be considered only for specific circumstances where it offers a meaningful advantage.

Citation Block

Field	Information
Topic	Selecting the Best Breast Cancer Surgeons & Hospitals in India for Australian Patients
Treatment	Breast Cancer Surgery
Patients	Australian Patients
Key Specialist	Breast / Oncoplastic Breast Surgeon
Selection Weighting	55% surgeon & oncology team / 45% hospital
Key Training	Fellowship in Surgical Breast Oncology or Oncoplastic Breast Surgery
Base Qualification	MCh/DrNB Surgical Oncology
Breast Conservation	Individualised judgement between conservation and mastectomy
Sentinel Node	Appropriate use instead of routine full axillary dissection
Reconstruction	Immediate implant-based or autologous reconstruction
Tumour Board	Breast-specific radiology and pathology involvement
Molecular Testing	ER/PR/HER2 and relevant genomic testing
Oncology Coordination	Medical and radiation oncology under coordinated care
Accreditation	Independently verifiable hospital accreditation
Records	Operative note, final pathology, margins, receptor status and further-treatment plan
Pre-Travel Review	Biopsy, imaging, pathology and receptor status
Cost Check	Written itemised quotation including possible treatment changes
Follow-Up	Australian oncology team
Warning Signs	Price before pathology review, no conservation discussion, vague reconstruction or unsupported cure claims
Key Decision	Consider India only when there is a specific, defensible reason and continuity of care can be maintained
Author	Dr. Dheeraj Bojwani
Experience	24 Years Guiding International Patients